• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AAO initiates EyeSmart program to educate about eye disease

Article

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

Only 11% of Americans find themselves at high risk for eye disease according to a survey conducted by Greenberg Quinlan Rosner Research. Americans over the age of 65 are the most at risk, however, only 10% believe they are at risk.

Age-related eye diseases such as cataract, diabetic retinopathy, glaucoma, and age-related macular degeneration are expected to increase from 28 million to 43 million by the year 2020, according to the organization. Americans are more concerned with weight gain and joint and back pain then they are with vision loss.

The AAO recommends that adults with no signs or risk factors for eye disease get a baseline eye disease screening at age 40. People with a family history of eye disease, diabetes, or high blood pressure should consult their physician to determine how often an examination is needed.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.